Abivax
Manufacturing · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
7-11 Boulevard Haussmann, Paris, Ile-de-...Phone Number
+33 153830963Website
www.abivax.comRevenue
<$5 MillionStock Symbol
ABVXIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Abivax
Abivax, a clinical stage biotechnology company, is mobilizing the body's natural immune machinery to treat patients with autoimmune diseases, viral infections, and cancer. Abivax was founded in 2013 and based in Paris, France.Explore more
Abivax Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Abivax your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Abivax has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Abivax
Funding: Get notified immidiatlly once Abivax has new funding data
Earning: See what the market has to say on Abivax recently announced quarterly report
Check out if Abivax is spiking on competitors!
Abivax, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Abivax launches new products
Click to see if Abivax had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Abivax is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Abivax is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Abivax.
Abivax financials insights
Gather financial insights about Abivax, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Debt
$436K
2020
Debt
$17.6M
2022
Other Financing Round
$49M
Abivax Tech Stack
A closer look at the technologies used by Abivax
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Event
Person-Based
Events, Podcast
Project
, according to a mid-level source in data & analytics, has completed initiatives related to dashboards and data visualization within the last twelve months.
Business Intelligence, Database, Analytics & Insights, Data Management, Data Science, Design & Graphics, Mapping & GIS
Project
Business Intelligence, Analytics & Insights, Data Science
Abivax News & Media
Correction: Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary SharesAbivax announces trading resumption of its ordinary shares on Euronext Paris
Abivax announces trading resumption of its ordinary shares on Euronext ParisAbivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary SharesAbivax announces temporary trading halt of its ordinary shares on Euronext Paris
Abivax announces temporary trading halt of its ordinary shares on Euronext Paris
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Abivax
Sign Up For FreeTo access detailed company insights
Abivax, a clinical stage biotechnology company, is mobilizing the body's natural immune machinery to treat patients with autoimmune diseases, viral infections, and cancer. Abivax was founded in 2013 and based in Paris, France.... Read More
